HopeStage
Back to all studies
CompletedNCT01396447

Cariprazine or Placebo for Depression Related to Bipolarity

About this title

Safety, Tolerability, and Efficacy of Cariprazine in Participants With Bipolar Depression

Read the official source — NCT01396447

Researchers compared Cariprazine and placebo to find out how the approaches affected depression symptoms in people with bipolarity during a depressive episode.

Medication studyAges 18–65Multiple countries
The study in practice

Understand this study

What did researchers investigate?

Researchers compared Cariprazine and placebo to find out how the approaches affected depression symptoms in people with bipolarity during a depressive episode.

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Listed locations
Birmingham and 87 more locationsSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: July 26, 2011
Recruitment status
Completed
Enrollment listed in the registry
584
Sponsor
Forest Laboratories
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States, Canada, Bulgaria, ...
Age range
From 18 Years to 65 Years
Official registry ID
NCT01396447
Official title
Show the full official title

A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients With Bipolar Depression

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Birmingham, United States · Springdale, United States · Beverly Hills, United States

68 more locations
  • Cerritos, United States
  • Costa Mesa, United States
  • Oceanside, United States
  • Temecula, United States
  • Jacksonville, United States
  • Orlando, United States
  • Winter Park, United States
  • Atlanta, United States
  • Chicago, United States
  • Indianapolis, United States
  • Prairie Village, United States
  • Lake Charles, United States
  • Shreveport, United States
  • Flowood, United States
  • Creve Coeur, United States
  • Las Vegas, United States
  • Cherry Hill, United States
  • Marlton, United States
  • Albuquerque, United States
  • Brooklyn, United States
  • New York, United States
  • Canton, United States
  • Dayton, United States
  • Salem, United States
  • Allentown, United States
  • Media, United States
  • Lincoln, United States
  • Memphis, United States
  • Dallas, United States
  • Houston, United States
  • San Antonio, United States
  • Bellevue, United States
  • Seattle, United States
  • Kardzhali, Bulgaria
  • Kazanlak, Bulgaria
  • Lovech, Bulgaria
  • Novi Iskar, Bulgaria
  • Pazardzhik, Bulgaria
  • Pleven, Bulgaria
  • Plovdiv, Bulgaria
  • Sofia, Bulgaria
  • Tsarev Brod, Bulgaria
  • Tserova Koria, Bulgaria
  • Kelowna, Canada
  • Penticton, Canada
  • Chatham, Canada
  • Barranquilla, Colombia
  • Bogotá, Colombia
  • Pereira, Colombia
  • Arkhangelsk, Russia
  • Moscow, Russia
  • Nizhny Novgorod, Russia
  • Saint Petersburg, Russia
  • Samara, Russia
  • Saratov, Russia
  • Tomsk, Russia
  • Tver', Russia
  • Voronezh, Russia
  • Kerch, Ukraine
  • Kherson, Ukraine
  • Donetsk, Ukraine
  • Ivano-Frankivsk, Ukraine
  • Kharkiv, Ukraine
  • Kyiv, Ukraine
  • Odesa, Ukraine
  • Simferopol, Ukraine
  • Vinnytsia, Ukraine
  • Russia

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

Researchers compared Cariprazine and placebo to find out how the approaches affected depression symptoms in people with bipolarity during a depressive episode.

Who is behind this study?

The study sponsor is Forest Laboratories, a pharmaceutical company.

Did this study involve medication?

Yes. The study involved medication, including Placebo and Cariprazine.

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies